OG Anunoby’s emergence as a defensive force for the New York Knicks reflects a broader trend in NBA roster construction: the rising value of “future-proofed” wings who can switch across multiple positions. According to scouting data from the Toronto Raptors and Indiana University, Anunoby’s ability to anchor a defense while evolving his offensive toolkit—despite early-career injury setbacks—demonstrates how elite franchises now prioritize versatile, high-IQ players over traditional, single-skill specialists.

Why NBA teams are shifting toward “positionless” defenders

Modern NBA front offices are increasingly prioritizing players who can defend across four or five positions, a trend exemplified by Anunoby’s transition from a defensive specialist to a cornerstone of the Knicks’ rotation. According to former Raptors President Masai Ujiri, the organization targeted Anunoby specifically for his potential to adapt, even as he recovered from a 2017 ACL injury. This “future-proofing” strategy involves identifying athletes who possess both the physical frame to guard elite scorers like Victor Wembanyama and the basketball intelligence to execute complex defensive schemes. Unlike the rigid, role-based scouting of the early 2000s, today’s teams, such as the Knicks and Raptors, value “ugly intangibles”—the ability to tip balls, deflect passes, and screen without needing to dominate the box score.

Pro Tip: Look for players who maintain high offensive efficiency with low usage rates. These athletes, often termed “connectors,” are the most common targets for teams looking to build championship-caliber depth without sacrificing chemistry.

How injury history influences draft value and development

The “Anunoby model” of development highlights a significant divergence in how teams value injury-prone prospects. While an ACL tear or a broken wrist might have lowered a player’s draft stock in previous decades, teams now use these gaps in play to acquire high-upside talent at a discount. Anunoby slipped to the 23rd pick in 2017 due to his knee injury, a reality Ujiri openly acknowledged on draft night. This approach creates a “developmental runway” where teams can integrate a player slowly. By the time a player reaches their prime, they have often internalized the team’s defensive ethos, turning a perceived liability into a long-term asset.

The impact of high-IQ “connectors” on team success

The success of the 2025-2026 Knicks highlights the importance of players who prioritize team outcomes over individual statistics. According to Karl-Anthony Towns, Anunoby’s selfless playstyle is a manifestation of a “right hand of god” mentality, where contributions are measured by floor spacing and defensive positioning rather than volume scoring. This shift mirrors the evolution of the Golden State Warriors and the 2019 Raptors, where the team’s engine relied on “floor savants” like Kyle Lowry. As NBA defenses become more sophisticated, the value of a player who can “take himself out of the moment” to facilitate a teammate’s success has become the most sought-after trait in the league.

OG Anunoby Defensive Highlights | NY Knicks

Did you know?

OG Anunoby was not listed in the official programs for the Atlanta AAU tournament where he was first discovered by then-Indiana coach Tom Crean. He was playing with a broken wrist, forcing scouts to look past the official rosters to identify his raw potential.

Frequently Asked Questions

What makes OG Anunoby a “future-proof” player? He combines elite defensive versatility with a progressively improving offensive game, allowing him to fit into multiple system types regardless of his teammates’ skill sets.
Why are teams more willing to draft injured players now? Advanced medical staff and prolonged player development programs allow teams to treat recovery as part of the onboarding process, turning lower draft picks into high-value contributors.
How does the current Knicks roster compare to the championship-winning Raptors? Both teams rely on “non-blistering” offenses that prioritize high-IQ decision-making and defensive tenacity over individual star-driven isolation play.

Want to see more deep-dives into NBA scouting trends? Subscribe to our newsletter for weekly analysis on player development and league-wide roster strategies.

Breaking Barriers in Stem Cell Therapy: How Oxygen Levels Could Revolutionize Cancer Treatment and Beyond

New research from Indiana University School of Medicine reveals how oxygen sensitivity in stem cells could transform bone marrow transplants, cancer immunotherapy, and gene therapy—ushering in a new era of personalized medicine.

— ### The Oxygen Paradox: Why Your Body’s Low-Oxygen Environment Matters More Than You Think For decades, scientists have studied hematopoietic stem cells (HSCs)—the body’s master cells capable of regenerating blood, immune cells, and even repairing damaged tissues. But a groundbreaking study published in Leukemia flips the script: oxygen levels aren’t just a backdrop for these cells—they’re the unseen conductor orchestrating their fate. Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center discovered that HSCs are hyper-sensitive to oxygen fluctuations. Even brief exposure to different oxygen tensions—ranging from the bone marrow’s near-anoxia (1%) to circulating blood’s 14%—drastically alters how these cells differentiate, proliferate, and survive. Why does this matter? – Bone marrow transplants for leukemia or genetic disorders could see higher success rates. – CAR T-cell therapies (a cutting-edge cancer treatment) might function better if cultured in low-oxygen conditions. – Gene therapy for rare blood diseases could become more effective by mimicking the body’s natural environment. — ### The Science Behind the Breakthrough: How Oxygen Dictates Cell Behavior The study, co-led by James Ropa, PhD, Maegan Capitano, PhD, and Mark Kaplan, PhD, exposed HSCs from umbilical cord blood, bone marrow, and peripheral blood to varying oxygen levels—mirroring the body’s natural gradients. Key Findings: ✅ Differentiation Shifts: Cells grown in low oxygen (1-5%) produced distinct populations of blood cells compared to those in higher oxygen (10-14%). ✅ Engraftment Advantage: When transplanted into mice, cells cultured at lowest oxygen tensions (1%) showed the highest engraftment rates—meaning they thrived and integrated better in living systems. ✅ Stress Reduction: Lab incubators (typically 21% oxygen) stress HSCs unnecessarily. Cells cultured in lower oxygen were less stressed and functioned optimally. > “We’re essentially giving these cells a vacation from the stress of high oxygen,” says Capitano. “When we replicate their natural environment, they perform like champions.” — ### Real-World Applications: How This Research Could Save Lives #### 1. Bone Marrow Transplants: Fewer Failures, More Cures Every year, thousands of patients rely on HSC transplants to treat leukemia, lymphoma, and genetic blood disorders like Fanconi anemia. Yet, only about 30% of transplants from unrelated donors succeed due to poor cell survival. This study suggests that optimizing oxygen levels during cell expansion could: – Boost engraftment rates by keeping HSCs in their “happy zone.” – Reduce graft-versus-host disease (GVHD), a deadly complication where donor cells attack the patient’s body. – Expand the donor pool by improving the viability of cord blood units (currently limited by low cell counts). > Did You Know? > Fanconi anemia patients—whose defective stem cells struggle in normal oxygen—showed improved survival when exposed to hypoxia in previous IU research (2024). This new study builds on that, offering hope for broader applications. #### 2. Cancer Immunotherapy: Supercharging CAR T-Cells CAR T-cell therapy has revolutionized blood cancers like acute lymphoblastic leukemia (ALL), but only about 40% of patients respond long-term. One reason? The cells often lose potency during lab culturing. By adjusting oxygen levels: – CAR T-cells could retain their killing power longer after infusion. – Manufacturing could become more efficient, reducing costs and improving accessibility. – Personalized therapies might be tailored to each patient’s unique oxygen-sensitive cell profile. #### 3. Gene Therapy: Fixing Defective Stem Cells for Good For diseases like sickle cell anemia or thalassemia, gene-edited HSCs are the future. But current methods struggle with low engraftment. This research implies: – Gene-corrected cells could thrive better if cultured in low-oxygen conditions. – Fewer “failed” therapies, as cells remain functional post-transplant. — ### The Future of “Hypoxia-Engineered” Therapies: What’s Next? The Indiana University team isn’t stopping here. Their Hypoxia Core—a national resource for controlled-oxygen research—is already being used to: – Develop standardized low-oxygen protocols for clinical use. – Test hypoxia’s role in other cell types, like mesenchymal stem cells for tissue repair. – Explore oxygen’s impact on aging, since stem cell decline is linked to oxidative stress. Industry experts predict: 🔹 Within 5 years: Hospitals may use hypoxia chambers to pre-condition stem cells before transplants. 🔹 Within 10 years: Personalized oxygen maps could guide cell therapy optimization for each patient. 🔹 Long-term: Entire biotech pipelines may shift to low-oxygen culturing as the new standard. — ### FAQ: Your Burning Questions About Oxygen and Stem Cells

Q: Why do stem cells behave differently in low oxygen?

A: Stem cells evolved in the body’s low-oxygen (hypoxic) niches, like bone marrow. High oxygen triggers oxidative stress, damaging their DNA and reducing function. Low oxygen mimics their natural habitat, keeping them “alive, and kicking.”

Q: Could this make bone marrow transplants safer?

A: Absolutely. By reducing stress on donor cells, researchers hope to lower rejection rates and GVHD risks, making transplants more reliable for patients with limited donor matches.

Q: Will this affect CAR T-cell therapy costs?

A: Potentially. If cells survive and function better in low oxygen, fewer doses may be needed, cutting manufacturing costs and improving patient access.

Q: Are there risks to culturing cells in low oxygen?

A: Early research suggests minimal risks if done correctly. However, long-term studies are needed to ensure no unintended mutations or side effects occur.

Q: How soon could this change clinical practice?

A: 1-3 years for initial trials in controlled settings (e.g., cord blood banks). 5-10 years for widespread adoption, pending FDA/regulatory approvals.

— ### Pro Tip: How to Advocate for Better Stem Cell Therapies If you or a loved one relies on stem cell treatments, here’s how to push for faster adoption of hypoxia-based methods: 1. Ask your transplant center if they’re exploring low-oxygen culturing. 2. Support clinical trials like those at IU School of Medicine or this *Leukemia* study. 3. Join patient advocacy groups like the National Marrow Donor Program to demand innovation. — ### The Huge Picture: A New Era of “Environmental Medicine” This discovery is more than a scientific milestone—it’s a paradigm shift. For the first time, researchers are proving that a cell’s environment isn’t just important—it’s everything. As Mark Kaplan, PhD, puts it: > **”We’ve been treating cells like they’re one-size-fits-all, but they’re not. Oxygen is just one piece of the puzzle—but it’s a huge one. The future of medicine isn’t just about what we put into cells; it’s about where and how we grow them.”** — ### Call to Action: Stay Informed, Stay Engaged This research is just the beginning. The next breakthrough in stem cell therapy could be happening right now—will you be part of it? 🔹 Subscribe to our newsletter for updates on hypoxia research and personalized medicine. 🔹 Share this article with someone who could benefit from these advances. 🔹 Leave a comment below: *How do you think oxygen-sensitive therapies will change healthcare?* —

Indiana University

How OG Anunoby’s Path Led to His Knicks Moment